Hwabao WP Hang Seng Hong Kong Stock Connect Innovative Drugs Select Exchange Traded Fund UnitsHwabao WP Hang Seng Hong Kong Stock Connect Innovative Drugs Select Exchange Traded Fund UnitsHwabao WP Hang Seng Hong Kong Stock Connect Innovative Drugs Select Exchange Traded Fund Units

Hwabao WP Hang Seng Hong Kong Stock Connect Innovative Drugs Select Exchange Traded Fund Units

No trades
No trades

Compare with Hwabao WP Hang Seng Hong Kong Stock Connect Innovative Drugs Select Exchange Traded Fund Units



Key stats


Assets under management (AUM)
‪1.94 B‬CNY
Fund flows (1Y)
‪−713.14 M‬CNY
Dividend yield (indicated)
Discount/Premium to NAV
−100.0%
Shares outstanding
0.00
Expense ratio

Fund info


Issuer
Hwabao WP Fund Management Co., Ltd.
Brand
Hwabao
Home page
Structure
Open-Ended Fund
Index tracked
Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Hwabao WP Fund Management Co., Ltd.
ISIN
CNE100006XY4
FIGI
BBG01VCX49L7
Identifiers
ISIN CNE100006XY4
Functions as an exchange traded fund

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
520880 trades at 0.446 CNY today, its price has risen 0.68% in the past 24 hours. Track more dynamics on 520880 price chart.
520880 net asset value is 4,371,618,000.00 today — it's fallen 11.57% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
520880 assets under management is ‪1.94 B‬ CNY. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
520880 price has fallen by −1.55% over the last month, and its yearly performance shows a −29.54% decrease. See more dynamics on 520880 price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −11.57% over the last month, showed a −28.31% decrease in three-month performance and has increased by 4.10% in a year.
520880 fund flows account for ‪−713.14 M‬ CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
No, 520880 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 520880 technical analysis shows the sell rating and its 1-week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 520880 shows the sell signal. See more of 520880 technicals for a more comprehensive analysis.
No, 520880 doesn't pay dividends to its holders.
520880 trades at a premium (100.00%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
520880 shares are issued by Hwabao WP Fund Management Co., Ltd.
520880 follows the Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.